Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-026540
Filing Date
2017-11-16
Accepted
2017-11-16 12:19:46
Documents
1
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4222
  Complete submission text file 0000899243-17-026540.txt   6222
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 171207352

Mailing Address SNIPWEG 26 CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH TARGET N V (Reporting) CIK: 0001259870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 171207353

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)